These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31866086)

  • 1. Discussion.
    Wolf AS
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1556. PubMed ID: 31866086
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary: The association between hormone-replacement therapy and non-small cell lung cancer in women.
    Kozower BD
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1557. PubMed ID: 31727350
    [No Abstract]   [Full Text] [Related]  

  • 3. Smoking, hormonal factors and molecular markers in female lung cancer.
    Schveigert D; Krasauskas A; Didziapetriene J; Kalibatiene D; Cicenas S
    Neoplasma; 2016; 63(4):504-9. PubMed ID: 27268911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy in menopause and lung cancer: an update.
    La Vecchia C
    Eur J Cancer Prev; 2006 Jun; 15(3):189-90. PubMed ID: 16679859
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormone replacement therapy in menopause and lung cancer: an update.
    La Vecchia C
    Eur J Cancer Prev; 2006 Aug; 15(4):283-4. PubMed ID: 16835498
    [No Abstract]   [Full Text] [Related]  

  • 6. Decreased lung cancer survival with hormone-replacement therapy: caused by a decreased tissue factor pathway inhibitor level?
    Negaard HF; Eilertsen AL; Dahm A; Iversen PO; Østenstad B; Sandset PM
    J Clin Oncol; 2006 Jun; 24(17):2683-4; author reply 2684. PubMed ID: 16763285
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of cancerous lung metastases with androgens. Report on a successful treatment].
    THIEL H
    Dtsch Med Wochenschr; 1962 Mar; 87():505-6. PubMed ID: 14039698
    [No Abstract]   [Full Text] [Related]  

  • 8. A lung cancer responding to hormonal therapy.
    Collins IM; Nicholson SA; O'Byrne KJ
    J Thorac Oncol; 2010 May; 5(5):749-50. PubMed ID: 20421769
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormone Replacement Therapy and Colorectal Cancer Incidence and Mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Symer MM; Wong NZ; Abelson JS; Milsom JW; Yeo HL
    Clin Colorectal Cancer; 2018 Jun; 17(2):e281-e288. PubMed ID: 29398422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy and lung cancer risk in women: a meta-analysis of cohort studies: Hormone replacement therapy and lung cancer risk.
    Jin C; Lang B
    Medicine (Baltimore); 2019 Dec; 98(51):e17532. PubMed ID: 31860945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in breast cancer incidence associated with reductions in the use of hormone replacement therapy.
    Silverman BG; Siegelmann-Danieli N; Braunstein R; Kokia ES
    Cancer Epidemiol; 2011 Feb; 35(1):11-6. PubMed ID: 21163720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone propionate in the treatment of pulmonary metastases from breast carcinoma; report of a case.
    KLASS A
    Can Med Assoc J; 1948 Jan; 58(1):66-8. PubMed ID: 18897549
    [No Abstract]   [Full Text] [Related]  

  • 13. Remarkable change in age-specific breast cancer incidence in the Swiss canton of Geneva and its possible relation with the use of hormone replacement therapy.
    Bouchardy C; Morabia A; Verkooijen HM; Fioretta G; Wespi Y; Schäfer P
    BMC Cancer; 2006 Mar; 6():78. PubMed ID: 16551373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Nyirjesy I
    Lancet; 2003 Oct; 362(9392):1330; author reply 1330-1. PubMed ID: 14575990
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormone replacement therapy and lung cancer risk: a case-control analysis.
    Schabath MB; Wu X; Vassilopoulou-Sellin R; Vaporciyan AA; Spitz MR
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):113-23. PubMed ID: 14734459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and lobular breast carcinoma.
    Maric RN; Cheng KK
    Cancer; 2000 Oct; 89(8):1867-8. PubMed ID: 11042586
    [No Abstract]   [Full Text] [Related]  

  • 17. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Van Leeuwen FE; Rookus MA
    Lancet; 2003 Oct; 362(9392):1330; author reply 1330-1. PubMed ID: 14575989
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormonal Replacement Therapy and the Risk of Lung Cancer in Women: An Adaptive Meta-analysis of Cohort Studies.
    Bae JM; Kim EH
    J Prev Med Public Health; 2015 Nov; 48(6):280-6. PubMed ID: 26639742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of hormone replacement therapy on the incidence of breast cancer in Norway.
    Bakken K; Lund E; Eggen AE
    J Clin Oncol; 2005 May; 23(15):3636-7; author reply 3637-8. PubMed ID: 15908680
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Garton M
    Lancet; 2003 Oct; 362(9392):1328; author reply 1330-1. PubMed ID: 14575985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.